The FDA has granted approval to Valneva's Ixchiq vaccine, making it the first-ever vaccine for the chikungunya virus, a mosquito-borne disease causing severe joint pain.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.